PAIN THERAPEUTICS INC (PTIE) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 567 transactions totaling $87.1M, demonstrating a bearish sentiment with -$45.6M in net insider flow. The most recent transaction on Oct 3, 2018 involved a sale of 512,660 shares valued at $671.6K.
No significant insider buying has been recorded for PTIE in the recent period.
No significant insider selling has been recorded for PTIE in the recent period.
Based on recent SEC filings, insider sentiment for PTIE is bearish with an Insider Alignment Score of 24/100 and a net flow of -$45.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at PAIN THERAPEUTICS INC (PTIE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading PTIE stock, having executed 567 transactions in the past 90 days. The most active insider is Capital Management Llc/ca Eastbourne (Executive), who has made 72 transactions totaling $36.8M.
Get notified when executives and directors at PTIE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 3, 2018 | Master Fund Ltd. Armistice Capital | Executive | Sale | 512,660 | $1.31 | $671.6K | Large |
| Oct 3, 2018 | Master Fund Ltd. Armistice Capital | Executive | Sale | 0 | $N/A | $0 | |
| Oct 3, 2018 | Master Fund Ltd. Armistice Capital | Executive | Sale | 0 | $N/A | $0 | |
| Sep 27, 2018 | Robertson Sanford | Executive | Purchase | 37,817 | $1.05 | $39.7K | |
| Sep 26, 2018 | Robertson Sanford | Executive | Purchase | 30,992 | $1.05 | $32.5K | |
| Sep 25, 2018 | Robertson Sanford | Executive | Purchase | 21,420 | $1.00 | $21.4K | |
| Sep 24, 2018 | Robertson Sanford | Executive | Purchase | 9,771 | $0.96 | $9.4K | |
| Aug 20, 2018 | Boyd Steven | Executive | Sale | 0 | $N/A | $0 | |
| Aug 20, 2018 | Boyd Steven | Executive | Sale | 8,000 | $0.91 | $7.3K | |
| Aug 20, 2018 | Boyd Steven | Executive | Sale | 0 | $N/A | $0 | |
| Aug 17, 2018 | Boyd Steven | Executive | Sale | 0 | $N/A | $0 | |
| Aug 17, 2018 | Boyd Steven | Executive | Sale | 48,000 | $0.95 | $45.6K | |
| Aug 17, 2018 | Boyd Steven | Executive | Sale | 0 | $N/A | $0 | |
| Aug 16, 2018 | Boyd Steven | Executive | Sale | 1,200,000 | $1.02 | $1.2M | Large |
| Aug 16, 2018 | Boyd Steven | Executive | Sale | 0 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 303 | $66.3M | 55.5% |
Purchase(P) | 132 | $20.7M | 17.4% |
Payment(F) | 20 | $15.0M | 12.6% |
Exercise(M) | 25 | $13.9M | 11.7% |
Other(J) | 30 | $2.4M | 2.0% |
Exercise (Options)(X) | 12 | $823.2K | 0.7% |
Award(A) | 15 | $216.0K | 0.2% |
Gift(G) | 30 | $0 | 0.0% |
Insider selling pressure at PAIN THERAPEUTICS INC has increased, with 13 insiders executing 567 transactions across all time. Total sales of $66.3M significantly outpace purchases of $20.7M, resulting in a net outflow of $45.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.